[Delayed type hypersensitivity reactions to "Candida albicans" in mice (author's transl)]. 1978

B Hurtrel, and P H Lagrange

Mice injected intravenously (IV) or subcutaneously (SC) with living Candida albicans developed subsequently delayed-type hypersensitivity (DTH) which was measured in vivo by the footpad test after injection of 10(6) heat killed C. albicans (HKC.a.). Compared to systemic injections, SC immunizations with living C.a. gave higher levels of DTH, and lethality was absent. Subcutaneous injections of hundred time more doses of HKC.a. were also able to produce in normal mice a DTH reaction elicited with HKC.a. or with C.a. soluble extracts, but not with candidine. Intraperitoneal injections of varying doses of HKC.a. or subcutaneous injections of varying doses of C.a. soluble extracts failed to produce significant DTH. High levels of sensitization can be induced by using cyclophosphamide or BCG or both pretreatment before immunization, which seems to indicate immunomodulating factors for induction or expression of DTH in normal mice after injections of HKC.a. Kinetics of the local reaction elicited with HKC.a. fulfull usual criteria of DTH in actively immunized mice after CY pretreatment or not, and in passively immunized mice after systemic or local transfer of spleen cells from actively immune donors. Serum from same group of donors was unable to transfer DTH.

UI MeSH Term Description Entries
D006968 Hypersensitivity, Delayed An increased reactivity to specific antigens mediated not by antibodies but by sensitized T CELLS. Hypersensitivity, Tuberculin-Type,Hypersensitivity, Type IV,Tuberculin-Type Hypersensitivity,Type IV Hypersensitivity,Delayed Hypersensitivity,Delayed Hypersensitivities,Hypersensitivity, Tuberculin Type,Tuberculin Type Hypersensitivity,Tuberculin-Type Hypersensitivities,Type IV Hypersensitivities
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007116 Immunization, Passive Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER). Convalescent Plasma Therapy,Immunoglobulin Therapy,Immunotherapy, Passive,Normal Serum Globulin Therapy,Passive Antibody Transfer,Passive Transfer of Immunity,Serotherapy,Passive Immunotherapy,Therapy, Immunoglobulin,Antibody Transfer, Passive,Passive Immunization,Therapy, Convalescent Plasma,Transfer, Passive Antibody
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D009163 Mycobacterium bovis The bovine variety of the tubercle bacillus. It is called also Mycobacterium tuberculosis var. bovis. BCG,Calmette-Guerin Bacillus
D002176 Candida albicans A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D005260 Female Females

Related Publications

B Hurtrel, and P H Lagrange
August 1990, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
B Hurtrel, and P H Lagrange
June 1977, Immunitat und Infektion,
B Hurtrel, and P H Lagrange
May 1989, Photochemistry and photobiology,
B Hurtrel, and P H Lagrange
September 1994, International archives of allergy and immunology,
B Hurtrel, and P H Lagrange
May 1980, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
B Hurtrel, and P H Lagrange
November 1978, Laryngologie, Rhinologie, Otologie,
B Hurtrel, and P H Lagrange
July 1980, Nihon saikingaku zasshi. Japanese journal of bacteriology,
B Hurtrel, and P H Lagrange
April 2000, Inflammation research : official journal of the European Histamine Research Society ... [et al.],
B Hurtrel, and P H Lagrange
November 1978, Revista medica de Chile,
Copied contents to your clipboard!